NEW MJ NEWS

Ayr Wellness Inc. (CSE: AYR.A, OTC: AYRWF) (“Ayr” or the “Company”), a leading vertically integrated cannabis multi-state operator, today announced that it has received the requisite consent of holders (“Noteholders”) of its 12.5% senior secured notes due 2024 (the “Notes”) for the proposed amendment to the trust indenture governing the Notes.

As announced on October 1, 2021, a meeting of Noteholders was scheduled for October 26, 2021. However, as Noteholders representing a majority of the principal amount of the outstanding Notes delivered valid consents in favor of the proposed amendment by 4:00 p.m. (Toronto time) on October 18, 2021 (the “Consent Deadline”), the resolution approving the proposed amendments has been passed and the meeting has been cancelled.

The amendment is described in the joint notice of meeting and consent solicitation statement and accompanying management information circular (the “Circular”), which was filed on SEDAR on October 1, 2021. As described in the Circular, Noteholders who responded to the Consent Solicitation and provided consent will receive a consent fee of US$0.25 for each $1,000 principal amount of Notes. The amendment to the trust indenture will be filed on SEDAR following its execution.

About Ayr Wellness
Ayr is an expanding vertically integrated, U.S. multi-state cannabis operator, focused on delivering the highest quality cannabis products and customer experience throughout its footprint. Based on the belief that everything starts with the quality of the plant, the Company is focused on superior cultivation to grow superior branded cannabis products. Ayr strives to enrich consumers’ experience every day through the wellness and wonder of cannabis.

Ayr’s leadership team brings proven expertise in growing successful businesses through disciplined operational and financial management, and is committed to driving positive impact for customers, employees and the communities they touch. For more information, please visit www.ayrwellness.com.

Company Contact:

Megan Kulick
Head of Investor Relations
T: (646) 977-7914
Email: IR@ayrwellness.com

Media Contact:

Robert Vanisko
VP, Corporate Communications
Email: robert.vanisko@ayrwellness.com

Investor Relations Contact:

Brian Pinkston
MATTIO Communications
T: (703) 926-9159
Email: ir@mattio.com
Email: ir@ayrwellness.com


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$CARA Form 8-K

Form 8-K for CARA THERAPEUTICS, INC. 11-Jan-2016 Regulation FD Disclosure, Financial Statements…

Green Thumb Industries Inc. (GTI) (GTBIF) Closes on Transaction With Innovative Industrial Properties

Green Thumb Industries (GTI) Closes on Transaction With Innovative Industrial Properties to…

Cresco Labs Inc. (CRLBF) Reports Third Quarter 2023 Financial Results

Cresco Labs Reports Third Quarter 2023 Financial Results Cresco Labs Inc. (CSE:…

Future Farm Technologies Inc. (FFRMF) and TCG Investments Begin Construction on Two Puerto Rico Medical Marijuana Dispensaries

Future Farm and TCG Investments Begin Construction on Two Puerto Rico Medical…